Legacy Wealth Asset Management LLC Lowers Stake in Balchem Co. (NASDAQ:BCPC)

Legacy Wealth Asset Management LLC reduced its position in Balchem Co. (NASDAQ:BCPC) by 3.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,852 shares of the basic materials company’s stock after selling 96 shares during the quarter. Legacy Wealth Asset Management LLC’s holdings in Balchem were worth $465,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of BCPC. Westside Investment Management Inc. purchased a new stake in Balchem in the 3rd quarter worth $27,000. nVerses Capital LLC purchased a new position in Balchem in the 3rd quarter worth approximately $35,000. Wilmington Savings Fund Society FSB bought a new position in Balchem in the 3rd quarter worth approximately $35,000. GAMMA Investing LLC grew its holdings in Balchem by 73.4% during the 3rd quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company’s stock valued at $148,000 after buying an additional 356 shares in the last quarter. Finally, Blue Trust Inc. raised its position in shares of Balchem by 642.5% during the third quarter. Blue Trust Inc. now owns 839 shares of the basic materials company’s stock valued at $148,000 after buying an additional 726 shares during the last quarter. 87.91% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. HC Wainwright raised their target price on shares of Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a research note on Monday, November 4th. StockNews.com upgraded Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th.

Balchem Trading Down 0.2 %

BCPC stock opened at $160.15 on Friday. The firm has a market cap of $5.21 billion, a PE ratio of 43.05, a price-to-earnings-growth ratio of 4.15 and a beta of 0.69. The firm has a fifty day moving average price of $170.60 and a 200 day moving average price of $170.77. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 2.98. Balchem Co. has a fifty-two week low of $136.74 and a fifty-two week high of $186.03.

Balchem Increases Dividend

The firm also recently announced an annual dividend, which was paid on Friday, January 17th. Stockholders of record on Thursday, December 26th were issued a $0.87 dividend. The ex-dividend date was Thursday, December 26th. This is an increase from Balchem’s previous annual dividend of $0.79. This represents a dividend yield of 0.4%. Balchem’s payout ratio is 23.39%.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.